Natalizumab (Tysabri) Re-Initiation of Dosing

PHASE3TerminatedINTERVENTIONAL
Enrollment

1,094

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Relapsing-Remitting Multiple Sclerosis
Interventions
DRUG

Natalizumab

Trial Locations (112)

4

Research Site, Dublin

1021

Research Site, Budapest

1023

Research Site, Auckland

1070

Research Site, Brussels

1115

Research Site, Budapest

1145

Research Site, Budapest

1204

Research Site, Budapest

1820

Research Site, Melsbroek

2050

Research Site, Camperdown

2100

Research Site, Copenhagen

3050

Research Site, Parkville

3084

Research Site, Heidelberg

3590

Research Site, Diepenbeek

4012

Research Site, Debrecen

4031

Research Site, Debrecen

Research Site, Basel

4400

Research Site, Nyíregyháza

6000

Research Site, Charleroi

6700

Research Site, Esbjerg

8000

Research Site, Bruges

Research Site, Aarhus C

Research Site, Székesfehérvár

8011

Research Site, Christchurch

8340

Research Site, Sijsele

9000

Research Site, Győr

11527

Research Site, Athens

12000

Research Site, Prague

13347

Research Site, Berlin

13385

Research Site, Marseille

16132

Research Site, Genova

16761

Research Site, Hennigsdorf

17176

Research Site, Stockholm

18147

Research Site, Rostock

20100

Research Site, Turku

20132

Research Site, Milan

21033

Research Site, Dijon

25030

Research Site, Besançon

29010

Research Site, Málaga

30625

Research Site, Hanover

31059

Research Site, Toulouse

33076

Research Site, Bordeaux

33520

Research Site, Tampere

34303

Research Site, Istanbul

34390

Research Site, Istanbul

35033

Research Site, Rennes

35385

Research Site, Giessen

41685

Research Site, Gothenburg

45122

Research Site, Essen

49076

Research Site, Osnabrück

52621

Research Site, Tel Litwinsky

54035

Research Site, Nancy

59037

Research Site, Lille

63003

Research Site, Clermont-Ferrand

63069

Research Site, Offenbach

67091

Research Site, Strasbourg

69677

Research Site, Lyon

70124

Research Site, Bari

75019

Research Site, Paris

75651

Research Site, Paris

81377

Research Site, München

91120

Research Site, Jerusalem

93053

Research Site, Regensburg

94101

Research Site, Créteil

V6T 2B5

Research Site, Vancouver

B3H IV7

Research Site, Halifax

K7L 2V7

Research Site, Kingston

N6A5A5

Research Site, London

M4N 3M5

Research Site, New York

K2G6E2

Research Site, Ottawa

M5B 1W8

Research Site, Toronto

J8Y 1W7

Research Site, Gatineau

J4V 2H1

Research Site, Greenfield Park

H3A2B4

Research Site, Montreal

625 00

Research Site, Brno

656 91

Research Site, Brno

500 05

Research Site, Hradec Králové

775 20

Research Site, Olomouc

708 52

Research Site, Ostrava

532 03

Research Site, Pardubice

323 00

Research Site, Pilsen

150 06

Research Site, Prague

00290

Research Site, Helsinki

00185

Research Site, Roma

5211 NL

Research Site, 's-Hertogenbosch

1081HV

Research Site, Amsterdam

4818 CK

Research Site, Breda

3435 CM

Research Site, Nieuwegein

6533 PA

Research Site, Nijmegen

3015 GD

Research Site, Rotterdam

15-402

Research Site, Bialystok

15-420

Research Site, Bialystok

85-681

Research Site, Bydgoszcz

80-803

Research Site, Gdansk

40-752

Research Site, Katowice

31-530

Research Site, Krakow

90-153

Research Site, Lodz

20-954

Research Site, Lublin

02-097

Research Site, Warsaw

02-957

Research Site, Warsaw

08035

Research Site, Barcelona

08907

Research Site, Barcelona

141 86

Research Site, Stockholm

06100

Research Site, Ankara

RM7 0AG

Research Site, Essex

L9 7AJ

Research Site, Liverpool

E1 1BB

Research Site, London

SE5 9RF

Research Site, London

SW17 0QT

Research Site, London

NE14LP

Research Site, Newcastle upon Tyne

OX3 9DU

Research Site, Oxford

S10 2JF

Research Site, Sheffield

ST4 7LN

Research Site, Stoke-on-Trent

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Biogen

INDUSTRY